Izumi H, Hayakari M
Eur J Pharmacol. 1986 Nov 4;130(3):279-86. doi: 10.1016/0014-2999(86)90279-7.
The role of the renin-angiotensin system in compound 48/80 (3 mg/kg s.c.)-induced thirst in rats was investigated. Bilateral nephrectomy attenuated drinking induced by compound 48/80 but not by polyethylene glycol (PEG) (30%, 5 ml s.c.). Pretreatment with tripelennamine (histamine H1-receptor antagonist, 40 mg/kg i.p.) prior to the administration of compound 48/80 reduced the effect of compound 48/80 on drinking, but pretreatment with cimetidine (histamine H2-receptor antagonist, 40 mg/kg i.p.) or propranolol (beta-adrenoceptor antagonist, 10 mg/kg i.p.) had no effect. The effect of SQ 14,225 (angiotensin converting enzyme inhibitor) in various concentrations (0.5-100 mg/kg s.c.) was investigated on the drinking response caused by compound 48/80 (3 mg/kg s.c.), PEG (30%, 5 ml s.c.), isoprenaline (0.5 mg/kg s.c.) and hypertonic saline (5.8%, 2 ml s.c.). SQ 14,225 at a dose of 50 mg/kg significantly attenuated the compound 48/80-induced water intake when administered within 30 min prior to the injection of compound 48/80. Pretreatment with a high dose of SQ 14,225 (50 or 100 mg/kg s.c.) 15 min prior to the injection of dipsogens caused inhibition of the drinking response to compound 48/80 or isoprenaline, but not to PEG or hypertonic saline. Pretreatment with lower doses of SQ 14,225 (0.5 or 5 mg/kg, s.c.) had no inhibitory effect on compound 48/80- or isoprenaline-induced water intake. The inhibition of water intake by SQ 14,225 seems to be dependent on the dose and time between administration of SQ 14,225 and compound 48/80 or isoprenaline. Compound 48/80 and hypertonic saline were additively effective in producing the drinking response.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了肾素 - 血管紧张素系统在化合物48/80(3毫克/千克,皮下注射)诱导的大鼠口渴中的作用。双侧肾切除减弱了化合物48/80诱导的饮水,但对聚乙二醇(PEG,30%,5毫升,皮下注射)诱导的饮水没有影响。在给予化合物48/80之前,用曲吡那敏(组胺H1受体拮抗剂,40毫克/千克,腹腔注射)预处理可降低化合物48/80对饮水的影响,但用西咪替丁(组胺H2受体拮抗剂,40毫克/千克,腹腔注射)或普萘洛尔(β肾上腺素能受体拮抗剂,10毫克/千克,腹腔注射)预处理则没有效果。研究了不同浓度(0.5 - 100毫克/千克,皮下注射)的SQ 14,225(血管紧张素转换酶抑制剂)对化合物48/80(3毫克/千克,皮下注射)、PEG(30%,5毫升,皮下注射)、异丙肾上腺素(0.5毫克/千克,皮下注射)和高渗盐水(5.8%,2毫升,皮下注射)引起的饮水反应的影响。在注射化合物48/80前30分钟内给予50毫克/千克剂量的SQ 14,225可显著减弱化合物48/80诱导的水摄入量。在注射致渴剂前15分钟用高剂量的SQ 14,225(50或100毫克/千克,皮下注射)预处理可抑制对化合物48/80或异丙肾上腺素的饮水反应,但对PEG或高渗盐水则无抑制作用。用较低剂量的SQ 14,225(0.5或5毫克/千克,皮下注射)预处理对化合物48/80或异丙肾上腺素诱导的水摄入量没有抑制作用。SQ 14,225对水摄入量的抑制作用似乎取决于SQ 14,225与化合物48/80或异丙肾上腺素给药之间的剂量和时间。化合物48/80和高渗盐水在产生饮水反应方面具有相加效应。(摘要截短至250字)